![General Commons Logo](./assets/images/crdc-logo.svg) 
# caNanoLab DOI 
-------------------------- 
## DOI:	Not Available 
**Protocol Name:**	CPMV-CH401 & QŒ?-CH401 In Vivo Efficacy Studies  
**Protocol Abbreviation:**	nan  
**Protocol Version:**	nan  
-------------------------- 
### Resource Type:	Protocol 
### Publication Status:	publication_status 
#### Created Date:	2025-05-14 01:27:00 
-------------------------- 
| Property | Value | 
|----------|---------| 
| Sample ID | 115900577 | 
| Sample Name | CPMV-CH401 & QÎ²-CH401 | 
| Organization | UCSD_Nanoengineering | 
| Characterization ID | 115574417|115574418|115574420|115574419|115574421|115574422|115574423 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vivo|in vivo | 
| Assay Type | ['Dynamic Light Scattering|PAGE|Gel electrophoresis|Transmission Electron Microscopy|Combination Immunotherapy|Humoral Immunity|cytokines induction'] | 
| Nanomaterial Entity Type | Virus nanoparticle | 
| Protocol ID | 114131175 | 
| Protocol Type | in vivo assay | 
| Protocol Name |CPMV-CH401 & QŒ?-CH401 In Vivo Efficacy Studies | 
| Composing Element Type | composing_element_type | 
| Composing Element Chemical Name | composing_element_chemical_name | 
| File Name | CPMV-CH401 & Q?é¬?-CH401 In Vivo Efficacy Studies.docx | 
| File URI | protocols/20250514_01-27-33-587_CPMV-CH401 & Q?é¬?-CH401 In Vivo Efficacy Studies.docx | 
| Nanomaterial Entity File Type | nanomaterial_entity_file_type | 
| Chemical Association File Type Title | chemical_association_file_type_title | 
